169 related articles for article (PubMed ID: 22544824)
1. Computational identification of self-inhibitory peptides from envelope proteins.
Xu Y; Rahman NA; Othman R; Hu P; Huang M
Proteins; 2012 Aug; 80(9):2154-68. PubMed ID: 22544824
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization of the feline-immunodeficiency-virus envelope glycoprotein 36 ectodomain for the development of new antivirals.
Desmaris F; Lemaire D; Ricard-Blum S; Chatrenet B; Forest E
Biochem J; 2005 Jul; 389(Pt 2):559-67. PubMed ID: 15799719
[TBL] [Abstract][Full Text] [Related]
3. The identification and characterization of fusogenic domains in herpes virus glycoprotein B molecules.
Galdiero S; Vitiello M; D'Isanto M; Falanga A; Cantisani M; Browne H; Pedone C; Galdiero M
Chembiochem; 2008 Mar; 9(5):758-67. PubMed ID: 18311743
[TBL] [Abstract][Full Text] [Related]
4. The membrane-proximal fusion domain of HIV-1 GP41 reveals sequence-specific and fine-tuning mechanism of membrane binding.
Efremov RG; Volynsky PE; Nolde DE; Vergoten G; Arseniev AS
J Biomol Struct Dyn; 2007 Oct; 25(2):195-205. PubMed ID: 17718599
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a role of the membrane-proximal region of herpes simplex virus type 1 glycoprotein H in membrane fusion and virus inhibition.
Galdiero S; Falanga A; Vitiello M; D'Isanto M; Collins C; Orrei V; Browne H; Pedone C; Galdiero M
Chembiochem; 2007 May; 8(8):885-95. PubMed ID: 17458915
[TBL] [Abstract][Full Text] [Related]
6. Peptide inhibitors of dengue virus and West Nile virus infectivity.
Hrobowski YM; Garry RF; Michael SF
Virol J; 2005 Jun; 2():49. PubMed ID: 15927084
[TBL] [Abstract][Full Text] [Related]
7. Hydrophobic alpha-helices 1 and 2 of herpes simplex virus gH interact with lipids, and their mimetic peptides enhance virus infection and fusion.
Gianni T; Fato R; Bergamini C; Lenaz G; Campadelli-Fiume G
J Virol; 2006 Aug; 80(16):8190-8. PubMed ID: 16873275
[TBL] [Abstract][Full Text] [Related]
8. A novel enzyme-linked immunosorbent assay for screening HIV-1 fusion inhibitors targeting HIV-1 Gp41 core structure.
Pang W; Wang RR; Gao YD; Yang LM; Sun Y; Huang JF; Tien P; Zheng YT
J Biomol Screen; 2011 Feb; 16(2):221-9. PubMed ID: 21297108
[TBL] [Abstract][Full Text] [Related]
9. Binding of antifusion peptides with HIVgp41 from molecular dynamics simulations: quantitative correlation with experiment.
Strockbine B; Rizzo RC
Proteins; 2007 May; 67(3):630-42. PubMed ID: 17335007
[TBL] [Abstract][Full Text] [Related]
10. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41.
Soonthornsata B; Tian YS; Utachee P; Sapsutthipas S; Isarangkura-na-Ayuthaya P; Auwanit W; Takagi T; Ikuta K; Sawanpanyalert P; Kawashita N; Kameoka M
Virology; 2010 Sep; 405(1):157-64. PubMed ID: 20580393
[TBL] [Abstract][Full Text] [Related]
12. Heptad repeat 2 in herpes simplex virus 1 gH interacts with heptad repeat 1 and is critical for virus entry and fusion.
Gianni T; Piccoli A; Bertucci C; Campadelli-Fiume G
J Virol; 2006 Mar; 80(5):2216-24. PubMed ID: 16474129
[TBL] [Abstract][Full Text] [Related]
13. Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.
Danial M; van Dulmen TH; Aleksandrowicz J; Pötgens AJ; Klok HA
Bioconjug Chem; 2012 Aug; 23(8):1648-60. PubMed ID: 22770564
[TBL] [Abstract][Full Text] [Related]
14. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.
Joshi SB; Dutch RE; Lamb RA
Virology; 1998 Aug; 248(1):20-34. PubMed ID: 9705252
[TBL] [Abstract][Full Text] [Related]
15. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
16. Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.
Herrera E; Tenckhoff S; Gómara MJ; Galatola R; Bleda MJ; Gil C; Ercilla G; Gatell JM; Tillmann HL; Haro I
J Med Chem; 2010 Aug; 53(16):6054-63. PubMed ID: 20718496
[TBL] [Abstract][Full Text] [Related]
17. Structural optimization and de novo design of dengue virus entry inhibitory peptides.
Costin JM; Jenwitheesuk E; Lok SM; Hunsperger E; Conrads KA; Fontaine KA; Rees CR; Rossmann MG; Isern S; Samudrala R; Michael SF
PLoS Negl Trop Dis; 2010 Jun; 4(6):e721. PubMed ID: 20582308
[TBL] [Abstract][Full Text] [Related]
18. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
[TBL] [Abstract][Full Text] [Related]
19. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.
Goncalvez AP; Purcell RH; Lai CJ
J Virol; 2004 Dec; 78(23):12919-28. PubMed ID: 15542644
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
Gustchina E; Hummer G; Bewley CA; Clore GM
J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
